Racial Differences Seen in Receipt of Lifesaving Stroke Treatments

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 19, 2023.

By Lori Solomon HealthDay Reporter

TUESDAY, Dec. 19, 2023 -- Black patients with acute ischemic stroke are significantly less likely to receive tissue plasminogen activator (tPA) and endovascular thrombectomy (EVT) than White patients, according to a study published online in the December issue of the Journal of Stroke & Cerebrovascular Diseases.

Delaney Metcalf, from the Medical College of Georgia and Augusta University/University of Georgia Medical Partnership in Athens, and Donglan Zhang, Ph.D., from NYU Grossman Long Island School of Medicine in Mineola, New York, examined racial and ethnic differences in receiving tPA and EVT as treatment for ischemic stroke. The analysis included 89,035 ischemic stroke patients identified from the 2019 National Inpatient Sample.

The researchers found that non-Hispanic Black patients had significantly lower odds of receiving tPA (adjusted odds ratio, 0.85) and EVT (adjusted odds ratio, 0.75) than non-Hispanic White patients. Overall, minority populations (non-Hispanic Black, Hispanic, Pacific Islander, Native American, and Asian) had significantly longer hospital length of stay after treatment with tPA or EVT. There were no significant differences between race/ethnicity and in-hospital mortality after tPA or EVT.

"This study calls for interventions to expand the utilization of tPA and EVT and advance quality of care post-tPA or EVT in order to improve stroke care for minority patients," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords